Product Data Sheet

α-Synuclein (71-82) (human)

Catalog No. A79433

main product photo
α-Synuclein (71-82) (human) is a peptide derived from the 71-82 fragment of the α-Synuclein protein, which is highly expressed in presynaptic nerve terminals. This peptide serves as a critical biomarker for the diagnosis and study of Parkinson's disease (PD). Its utility in research extends to understanding pathological mechanisms and potential therapeutic targets related to neurodegeneration in PD.
Chemical Information
Catalog NumA79433
M. Wt1158.35
FormulaC51H91N13O17
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.332867-16-0
Synonyms
SMILES
Biological Activity
Descriptionα-Synuclein (71-82) (human) is a peptide derived from the 71-82 fragment of the α-Synuclein protein, which is highly expressed in presynaptic nerve terminals. This peptide serves as a critical biomarker for the diagnosis and study of Parkinson's disease (PD). Its utility in research extends to understanding pathological mechanisms and potential therapeutic targets related to neurodegeneration in PD.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.